Product Information
EPINEPHRINE 0.3 MG AUTO-INJECT is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $132.8287 per EA under NDC 00093598627. Its NADAC has been published 353 times since Nov 20, 2019.
FDA first approved this application on Aug 16, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.3 mg/.3mL
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093598627
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR; SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
EPINEPHRINEApproval Type
Generic (ANDA)
FDA Application
ANDA090589FDA Approved
8/16/2018
TE Code
AB
On Market Since
11/27/2018
Pharmacological Classes
Price Statistics
The NADAC for EPINEPHRINE 0.3 MG AUTO-INJECT has been published 353 times since Nov 20, 2019, and over the history we have for it it has declined 6.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $132.8287 per EA |
|---|---|
| All-time high | $143.9528 (Jan 13, 2021) |
| All-time low | $124.0773 (May 22, 2024) |
| 52-week high | $137.6142 |
| 52-week low | $132.8287 |
| Median price | $137.7557 |
| Average price | $137.4177 |
| Largest weekly change | +11.3% (Jun 19, 2024) |
| Weeks tracked | 353 |
| Tracking since | Nov 20, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of EPINEPHRINE 0.3 MG AUTO-INJECT?
The current National Average Drug Acquisition Cost (NADAC) for EPINEPHRINE 0.3 MG AUTO-INJECT, manufactured by Teva Pharmaceuticals USA Inc., is $132.8287 per EA (NDC 00093598627), effective Aug 19, 2026.
How has the price of EPINEPHRINE 0.3 MG AUTO-INJECT changed over time?
Over the history we have for it, the NADAC for EPINEPHRINE 0.3 MG AUTO-INJECT has declined 6.2%. It has been tracked across 353 weekly CMS publications since Nov 20, 2019.
What are the highest and lowest recorded NADAC prices for EPINEPHRINE 0.3 MG AUTO-INJECT?
Since Nov 20, 2019, the NADAC for EPINEPHRINE 0.3 MG AUTO-INJECT has ranged from a low of $124.0773 (May 22, 2024) to a high of $143.9528 (Jan 13, 2021), with a median of $137.7557 per EA.
Are there cheaper alternatives to EPINEPHRINE 0.3 MG AUTO-INJECT?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as EPINEPHRINE 0.3 MG AUTO-INJECT in a comparable dosage form, but none are currently priced below it.
Who manufactures EPINEPHRINE 0.3 MG AUTO-INJECT?
EPINEPHRINE 0.3 MG AUTO-INJECT (NDC 00093598627) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.